Two Sigma Investments
ORIC icon

Two Sigma Investments’s Oric Pharmaceuticals ORIC Stock Holding History

Two Sigma Investments’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-76,990
Closed -$430K – 3433
2025
Q1 		$430K Sell
76,990
-62,693
-45% -$548K ﹤0.01% 2584
2024
Q4 		$1.13M Sell
139,683
-44,392
-24% -$407K ﹤0.01% 2100
2024
Q3 		$1.89M Sell
184,075
-78,439
-30% -$776K ﹤0.01% 1721
2024
Q2 		$1.86M Buy
262,514
+153,505
+141% +$1.37M ﹤0.01% 1602
2024
Q1 		$1.5M Buy
109,009
+3,999
+4% +$47.5K ﹤0.01% 1702
2023
Q4 		$966K Buy
105,010
+73,896
+238% +$534K ﹤0.01% 2102
2023
Q3 		$188K Sell
31,114
-75,501
-71% -$619K ﹤0.01% 2652
2023
Q2 		$827K Buy
106,615
+63,195
+146% +$359K ﹤0.01% 2057
2023
Q1 		$247K Sell
43,420
-3,149
-7% -$16.5K ﹤0.01% 2496
2022
Q4 		$274K Sell
46,569
-127,496
-73% -$430K ﹤0.01% 2276
2022
Q3 		$557K Sell
174,065
-61,271
-26% -$245K ﹤0.01% 1730
2022
Q2 		$1.05M Sell
235,336
-84,019
-26% -$335K ﹤0.01% 1522
2022
Q1 		$1.71M Buy
+319,355
New +$2.88M 0.01% 1432
2021
Q3 		– Sell
-30,641
Closed -$542K – 4573
2021
Q2 		$542K Buy
+30,641
New +$671K ﹤0.01% 3022

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Two Sigma Investments's ORIC Position: Q2 2025 in Review

Two Sigma Investments sold out of Oric Pharmaceuticals (ORIC) in Q2 2025, closing a stake of 76,990 shares — an estimated $430K sold.

Two Sigma Investments first reported a position in ORIC in Q2 2021 and held it in 14 quarters. The position peaked at $1.89M in Q3 2024. 142 funds tracked by Wall St. Rank hold ORIC as of Q2 2025.

  • Two Sigma Investments reported no remaining Oric Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Investments sold 76,990 Oric Pharmaceuticals shares in Q2 2025, an estimated $430K.
  • Two Sigma Investments first reported a position in Oric Pharmaceuticals in Q2 2021 and held it in 14 quarters.
  • Two Sigma Investments's Oric Pharmaceuticals position peaked at $1.89M in Q3 2024.
  • 142 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2025.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.